# Eli Lilly and Company (LLY) — Q1-2012 Earnings Results

**Report date:** 2012-04-25 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q1-2012

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Up 2.1%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.92 | N/A | +15.72% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Eli Lilly's strong EPS performance, exceeding expectations, led to a positive stock reaction, with shares rising 2.1%. The company did not disclose revenue figures or future guidance, leaving investors to focus on the EPS beat as a sign of operational strength. Overall, the results indicate a solid quarter for the company, but uncertainty remains without further guidance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q1-2012_